Excess Body Weight and Metabolic (Dysfunction)-Associated Fatty Liver Disease (MAFLD)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Excess Body Weight and Metabolic (Dysfunction)-Associated Fatty Liver Disease (MAFLD) ; volume:37 ; number:4 ; year:2021 ; pages:273-280 ; extent:8
Visceral medicine ; 37, Heft 4 (2021), 273-280 (gesamt 8)
- Creator
-
Roeb, Elke
- DOI
-
10.1159/000515445
- URN
-
urn:nbn:de:101:1-2021081900135796530812
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Roeb, Elke
Other Objects (12)
Metabolic dysfunction associated fatty liver disease in healthy weight individuals
Epidemiology and diagnosis of metabolic dysfunction-associated fatty liver disease
Hormone-based pharmacotherapy for metabolic dysfunction-associated fatty liver disease
Validation of fatty liver index as a marker for metabolic dysfunction-associated fatty liver disease
Excess Body Weight and Pancreatic Disease
Excess Body Weight and Gallstone Disease
Pediatric metabolic (dysfunction)-associated fatty liver disease: current insights and future perspectives
Metabolic (dysfunction)-associated fatty liver disease metrics and contributions to liver research
Risk Scores for Metabolic Dysfunction-Associated Fatty Liver Disease in Pediatric Obesity
Nuclear factor interleukin 3 and metabolic dysfunction-associated fatty liver disease development
Excess Body Weight and Gastrointestinal Cancer Risk
Excess Body Weight and Gastroesophageal Reflux Disease
Metabolic dysfunction associated fatty liver disease in healthy weight individuals
Epidemiology and diagnosis of metabolic dysfunction-associated fatty liver disease
Hormone-based pharmacotherapy for metabolic dysfunction-associated fatty liver disease
Validation of fatty liver index as a marker for metabolic dysfunction-associated fatty liver disease
Excess Body Weight and Pancreatic Disease
Excess Body Weight and Gallstone Disease
Pediatric metabolic (dysfunction)-associated fatty liver disease: current insights and future perspectives
Metabolic (dysfunction)-associated fatty liver disease metrics and contributions to liver research
Risk Scores for Metabolic Dysfunction-Associated Fatty Liver Disease in Pediatric Obesity
Nuclear factor interleukin 3 and metabolic dysfunction-associated fatty liver disease development
Excess Body Weight and Gastrointestinal Cancer Risk
Excess Body Weight and Gastroesophageal Reflux Disease
Metabolic dysfunction associated fatty liver disease in healthy weight individuals
Epidemiology and diagnosis of metabolic dysfunction-associated fatty liver disease
Hormone-based pharmacotherapy for metabolic dysfunction-associated fatty liver disease
Validation of fatty liver index as a marker for metabolic dysfunction-associated fatty liver disease
Excess Body Weight and Pancreatic Disease
Excess Body Weight and Gallstone Disease
Pediatric metabolic (dysfunction)-associated fatty liver disease: current insights and future perspectives
Metabolic (dysfunction)-associated fatty liver disease metrics and contributions to liver research
Risk Scores for Metabolic Dysfunction-Associated Fatty Liver Disease in Pediatric Obesity
Nuclear factor interleukin 3 and metabolic dysfunction-associated fatty liver disease development
Excess Body Weight and Gastrointestinal Cancer Risk